Israel’s Trobix Bio is using CRISPR, phage, and synthetic biology technologies to develop precision microbiome oncology therapeutics. TBX101 counters anti-biotic resistance; TBX201 reduces chemotherapy side-effects; TBX301 tackles gut inflammation.

https://www.trobix.bio/

https://www.youtube.com/watch?v=h1MsWkhBAyM